糖尿病并发症对糖尿病患者的寿命和生活质量造成了很大的影响，干细胞移植改善糖尿病患者的代谢控制和β细胞功能，随着干细胞技术的发展，给糖尿病及其并发症的治疗带来了新希望，

参考资料

【1】：Malmegrim KC，de Azevedo JT，Arruda LC，et a1．Immunologi— cal balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes． Front Immunol，2017，8：167．

【2】：Skyler JS，Fonseca VA，Segal KR，et a1．Allogeneic mesenchy— mal precursor cells in type 2 diabetes：A randomized，placebocontrolled，dose-escalation safe／y and tolerability pilot study． Diabetes Care，2015，38：1742—1749．

【3】：Lv S，Cheng J，Sun A，et a1．Mesenehymal stem cells transplan— tation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress．Dia— betes Res C1in Pract，2014，104：143—154．

【4】：Lv S，Liu G，Sun A，et a1．Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-beta signalling via secretion of bone morphogenetic pro— tein 7．Diab Vase Dis Ras，2014，1l：251—261．

【5】：Lupachyk S，Shevalye H，Maksimchyk Y，et a1．PARP inhibi— tion alleviates diabetes—indueed systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation：correla— tion with peripheral nerve function．Free Radic Biol Med， 2011，50：1400—1409．

【6】：Khan M，Ali F，Mohsin S，et a1．Preconditioning diabetic mesen— chymal stem cells with myogenic medium increases their ability to repair diabetic heart．Stem Cell Res Ther，2013，4：58．

来源：健康界